ホーム>>Signaling Pathways>> PI3K/Akt/mTOR Signaling>> Akt>>10-DEBC hydrochloride

10-DEBC hydrochloride (Synonyms: Akt Inhibitor X)

カタログ番号GC13006

10-DEBC 塩酸塩は選択的 Akt 阻害剤であり、IC50 は 1.28 μM です。

Products are for research use only. Not for human use. We do not sell to patients.

10-DEBC hydrochloride 化学構造

Cas No.: 925681-41-0

サイズ 価格 在庫数 個数
1mg
$63.00
在庫あり
5mg
$166.00
在庫あり
10mg
$213.00
在庫あり
50mg
$840.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Akt functions as a key component in multiple signaling pathways to promote cell survival by mediating resistance to apoptosis. Akt inhibitor X is a cell permeable phenoxazine derivative that suppresses insulin-like growth factor 1 (IGF-1)-stimulated phosphorylation of Akt with an IC50 value of 1-2 μM.[1] This compound has been shown to block IGF-1-stimulated nuclear translocation of Akt in Rh1 cells and to inhibit the growth of Rh1, Rh18, and Rh30 cells with IC50 values of 2-5 μM.[1] Inhibition of Akt phosphorylation by 5 μM of this compound strongly correlates to the inhibition of the downstream targets, mTOR, p70S6 kinase, and S6 ribosomal protein and to an increase in apoptosis.[1]

Reference:
[1]. Thimmaiah, K.N., Easton, J.B., Germain, G.S., et al. Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. The Journal of Biological Chemisty 280(36), 31924-31935 (2005).

レビュー

Review for 10-DEBC hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 10-DEBC hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.